As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...
Having access to less intrusive QT interval measurement with flexibility around the time and place of the appointment is important 3.1 Psychiatric service user experts explained that it is important ...
AliveCor is also offering a service called InstantQTâ„¢ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...
AliveCor has received clearance for its portable ECG to calculate a patient’s QTc Interval. This FDA action follows the enforcement policy for non-invasive devices issued by the agency in March 2020 ...
AliveCor's at-home EKG device won FDA clearance to calculate a heart's QT interval, a measurement of how long it takes the ventricles to contract and relax. This is vital given that some drugs can ...
Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...
The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending KardiaMobile 6L for measuring cardiac QT interval in people on antipsychotic medication. "It is the ...
The overall number of respondents was 517. Of about 608 attendees of Internal Medicine conferences, 371 (61%) responded, and of about 208 attendees of psychiatry conferences, 146 (67%) responded.
Uncertainty remains regarding the value of heart-rate-corrected QT interval (QTc) prolongation on electrocardiogram for predicting cardiovascular disease (CVD), particularly among Asian populations.
ADInstruments has announced that PowerLab systems are being used to establish the zebrafish as a model for assessing drug effects on cardiac function, using QT prolongation as a key indicator.
The diagnostics advisory committee considered evidence on KardiaMobile 6L for measuring QT interval from several sources, including an early value assessment report, cost and resource use report and ...